Supply Chain | November 12, 2021
Jubilant Biosys expands Chemistry Innovation Research Centre
The centre has an initial capacity of 500 FTEs
The centre has an initial capacity of 500 FTEs
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
Positive results reinforce the improved efficacy seen with Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer and melanoma
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
The transplant procedure was completed in under two hours
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
